Onral Oral Pain Reliever Mouthwash Liquid
NDC Package 85454-0421-1
Package Information
Onral Oral Pain Reliever Mouthwash (benzocaine) liquids is shake well upside down.Gargle, swish around in the mouth, or allow to remain in place for at least 1 minute and then spit out.Children under 12 years of age should be supervised in the use of the product.Apply to the affected area.Use up to 4 times daily or as directed by a dentist or doctor.Do not use for teething.Children under 2 years of age: Do not use. This formulation utilizes a liquid delivery system. Marketed by Syka Pharma Inc., this product is identified by NDC 85454-0421 and is authorized under FDA application M022.
Identification & Billing
- RxCUI: 2717653 - benzocaine 5 % Mouthwash
- RxCUI: 2717653 - benzocaine 50 MG/ML Mouthwash
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 85454 - Syka Pharma Inc.
- 85454-0421 - Onral Oral Pain Reliever Mouthwash
- 85454-0421-1 - 1 BOTTLE, PLASTIC in 1 CARTON / 230 mL in 1 BOTTLE, PLASTIC
- 85454-0421 - Onral Oral Pain Reliever Mouthwash
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85454-0421-1 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 230 ml in 1 bottle, plastic of Onral Oral Pain Reliever Mouthwash, a human over the counter drug labeled by Syka Pharma Inc.. This liquid is formulated for oral use and contains benzocaine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Syka Pharma Inc. on July 01, 2025. The current certification is valid through December 31, 2026.
How is this Syka Pharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85454042101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.